ATE62248T1 - Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln. - Google Patents

Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln.

Info

Publication number
ATE62248T1
ATE62248T1 AT88100677T AT88100677T ATE62248T1 AT E62248 T1 ATE62248 T1 AT E62248T1 AT 88100677 T AT88100677 T AT 88100677T AT 88100677 T AT88100677 T AT 88100677T AT E62248 T1 ATE62248 T1 AT E62248T1
Authority
AT
Austria
Prior art keywords
production
doxorubic
derivative
pharmaceutical compositions
medicinal products
Prior art date
Application number
AT88100677T
Other languages
English (en)
Inventor
Giuseppe Cassinelli
Teresa Bordoni
Sergio Merli
Giovanni Rivola
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Application granted granted Critical
Publication of ATE62248T1 publication Critical patent/ATE62248T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88100677T 1987-01-22 1988-01-19 Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln. ATE62248T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878701381A GB8701381D0 (en) 1987-01-22 1987-01-22 Antitumor agent
EP88100677A EP0275966B1 (de) 1987-01-22 1988-01-19 Ein Doxorubicinderivat, ein Verfahren zu dessen Herstellung, pharmazeutische Zusammensetzungen und dessen Verwendung für die Herstellung von Arzneimitteln
CA000572117A CA1294911C (en) 1987-01-22 1988-07-15 Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin
HU883699A HU201972B (en) 1987-01-22 1988-07-15 Process for producing antitumour 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin hydrochloride by stereoselective microbiological reduction of 4'-deoxy-4'-iododoxorubicin

Publications (1)

Publication Number Publication Date
ATE62248T1 true ATE62248T1 (de) 1991-04-15

Family

ID=27167996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88100677T ATE62248T1 (de) 1987-01-22 1988-01-19 Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln.

Country Status (12)

Country Link
US (1) US4895933A (de)
EP (1) EP0275966B1 (de)
JP (1) JP2592479B2 (de)
CN (1) CN1039617A (de)
AT (1) ATE62248T1 (de)
CA (1) CA1294911C (de)
DE (1) DE3862196D1 (de)
ES (1) ES2036602T3 (de)
GB (1) GB8701381D0 (de)
GR (1) GR3001717T3 (de)
HU (1) HU201972B (de)
ZA (1) ZA884653B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601857B2 (en) * 1988-06-30 1990-09-20 Pharmacia & Upjohn S.P.A. A new antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin
IT1285777B1 (it) * 1996-10-07 1998-06-18 Indena Spa Processo di biotrasformazione di composti colchicinoidi nei corrispondenti 3-glicosilderivati
DE60328486D1 (de) 2002-05-24 2009-09-03 Angiotech Int Ag Zusammensetzungen und verfahren zur beschichtung medizinischer implantate
EP1542739B1 (de) 2002-09-26 2008-12-10 Angiotech International Ag Perivaskuläre hüllen
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP3779446A1 (de) 2013-12-11 2021-02-17 University of Massachusetts Zusammensetzungen und verfahren zur behandlung einer krankheit mithilfe des salmonella-t3ss-effektorproteins (sipa)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970641A (en) * 1971-01-20 1976-07-20 Rhone-Poulenc S.A. Antibiotic 27,706 RP and salt thereof
US4427664A (en) * 1981-05-29 1984-01-24 The United States Of America As Represented By The Department Of Health And Human Services 2'Halo derivatives of daunomycin, desmethoxy daunomycin, adriamycin and carminomycin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides

Also Published As

Publication number Publication date
DE3862196D1 (de) 1991-05-08
HU201972B (en) 1991-01-28
GR3001717T3 (en) 1992-11-23
JP2592479B2 (ja) 1997-03-19
ZA884653B (en) 1989-03-29
EP0275966A1 (de) 1988-07-27
JPS63218694A (ja) 1988-09-12
HUT50513A (en) 1990-02-28
ES2036602T3 (es) 1993-06-01
CA1294911C (en) 1992-01-28
CN1039617A (zh) 1990-02-14
EP0275966B1 (de) 1991-04-03
GB8701381D0 (en) 1987-02-25
US4895933A (en) 1990-01-23

Similar Documents

Publication Publication Date Title
DE69023934D1 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
ATE212628T1 (de) Magnesium-omeprazol
ATE135712T1 (de) Polypeptid, dessen verfahren zur herstellung und dieses enthaltende pharmazeutische zusammensetzung und deren benutzung
ATE425973T1 (de) Depsipeptid-derivat, verfahren zu dessen herstellung und zwischenprodukt dafur
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
ATE62248T1 (de) Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln.
ATE50776T1 (de) Anthracyclin-derivate, ein mikrobiologisches verfahren zu ihrer herstellung und ihre verwendung als cytostatika.
ATE55250T1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
HU910506D0 (en) Process for producing 20, 21-dinoreburnamenine derivatives substituted inthe 9,10 and/or 11-location and pharmaceutical preparatives containing said compounds
AU1554592A (en) Interleukin 6 composition and production thereof
DE68916659D1 (de) WS-9326 A, WS-9326B und deren Derivate.
DE68924991D1 (de) 2-Pyranon-Derivat und Verfahren zu dessen Herstellung.
EP0487996B1 (de) 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
HUT60927A (en) Process for producing pharmaceutical composition inhibiting the formation of activated lymphocytes
JPS6456661A (en) Amino pyridine derivative
DE3865362D1 (de) Derivat von benzo(b)thiophen-7-carboxylsaeure, verfahren zu dessen herstellung und dieses enthaltende arzneimittel.
DE69011952D1 (de) Physiologisch aktive Verbindungen SN-198C sowie Verfahren und Bakterien zu deren Herstellung.
MX9803556A (es) Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producirlos.
MX9803557A (es) Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producir tales compuestos.
ATE124945T1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.
PT87972A (pt) Processo para a preparacao de4'-deoxi-13(s)-dihidro-4'-iododoxorubicina com actividade anti-tumor mediante reducao estereo-selectiva microbiana de 4'-deoxi-4'-iododoxorubicina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee